Brought to you by:
Aquedeon Medical receives FDA approval to expand clinical trial of Duett vascular graft system
The Food and Drug Administration (FDA) has approved the expansion of Aquedeon Medical’s investigational device exemption (IDE) clinical trial evaluating the Duett vascular graft system, a company press release reveals. Duett is a novel device designed to facilitate open surgical repair…
In wake of President Trump’s chronic venous insufficiency diagnosis, SVS steps up to educate public
News that U.S. President Donald J. Trump has a vascular condition may have simultaneously revealed that a substantial seven-figure vascular surgery branding campaign was starting to yield tangible results, and provided a singular opportunity to platform the specialty as the…
Regional vascular societies gear up for fall annual meetings
The glut of early fall regional vascular society annual meetings is just around the corner, with no fewer than five slated for the month of September. Several have recently made announcements about standout events taking place at their conferences, with…
SVS Executive Board votes against creating free-standing Vascular Surgery Board
After two years of careful deliberation, the Society for Vascular Surgery (SVS) Executive Board (EB) has voted against pursuing the creation of a free-standing Vascular Surgery Board (VSB), opting instead to maintain the current federated board structure under the American…
Analysis of BEST-CLI, PREVENT III reveals significant improvement in vein bypass outcomes over 20-year period
A post-hoc comparison of the BEST-CLI and PREVENT III multicenter, prospective, randomized controlled trials (RCTs) aimed at evaluating outcomes of vein bypass in chronic limb threatening ischemia (CLTI) patients over the past two decades found that they had “significantly improved”…
Early bird pricing deadline for coding workshop falls tomorrow
The early bird pricing deadline for this year’s SVS Coding & Reimbursement Workshop is tomorrow. With significant coding changes going into effect for vascular surgery on Jan. 1, 2026, the Society is urging vascular surgeons, trainees, advanced practice providers (APPs),…
‘Critical’ importance of lifelong surveillance after EVAR headlines newly published 10-year ENGAGE data
Ten-year data highlight the long-term efficacy and durability of the Endurant stent graft (Medtronic) in abdominal aortic aneurysm (AAA) patients who survived beyond five years post-enrollment in the ENGAGE registry. However, researchers also draw attention to the incidence of late…
New APP Section: A ‘professional home’
There’s no place like home within the newly established SVS Advanced Practice Provider (APP) Section, where vascular advanced practice registered nurses (APRNs) and physician assistants (PAs) aim to provide a “professional home” for APRNs and PAs working in vascular care…
Deadline extended for SVS Foundation grant focused on women’s health
The Society for Vascular Surgery (SVS) Foundation has extended the deadline for a Vascular Care for the Underserved (VC4U) project grant focused on women’s vascular health to Sept. 8. The $20,000 award, in partnership with the SVS Women’s Section, is…
Inari Medical, now part of Stryker, launches InThrill thrombectomy system
Inari Medical—now part of Stryker—has announced the launch of its next-generation InThrill thrombectomy system. The company stated in a recent press release that this is the “first and only purpose-built” small vessel and arteriovenous (AV) access thrombectomy system that can…